Kukje Pharma Co., Ltd. (KRX:002720)
South Korea · Delayed Price · Currency is KRW 4,870.00
+85.00 (1.78%)
Apr 1, 2026, 3:30 PM KST
Kukje Pharma Market Cap
Kukje Pharma has a market cap or net worth of 97.43 billion as of April 1, 2026. Its market cap has decreased by -2.94% in one year.
Market Cap
97.43B
Enterprise Value
117.13B
Revenue
175.50B
Ranking
n/a
PE Ratio
17.09
Stock Price
4,870.00
Market Cap Chart
Since July 3, 2006, Kukje Pharma's market cap has increased from 29.64B to 97.43B, an increase of 228.71%. That is a compound annual growth rate of 6.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 99.17B | 13.26% |
| Dec 30, 2025 | 87.56B | -15.02% |
| Dec 30, 2024 | 103.03B | -14.06% |
| Dec 28, 2023 | 119.89B | 12.98% |
| Dec 29, 2022 | 106.12B | -5.98% |
| Dec 30, 2021 | 112.86B | -36.19% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Daihan Pharmaceutical | 170.52B |
| Hana Pharm | 168.31B |
| Dongwha Pharm.Co.,Ltd | 166.86B |
| Ilsung Is | 162.03B |
| HANDOK | 139.65B |
| Jeil Pharma Holdings | 134.02B |
| Ildong Holdings | 119.24B |
| CKD Bio | 106.48B |